Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.621 USD | +2.88% | +16.98% | +20.89% |
05-09 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
04-01 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.89% | 72.68M | |
+9.10% | 114B | |
+11.46% | 104B | |
-12.66% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-2.93% | 17.89B | |
+8.27% | 14.28B | |
+34.99% | 12.55B |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- JPMorgan Adjusts Price Target on Atara Biotherapeutics to $22 From $27, Reiterates Overweight Rating